Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2008
12/11/2008CA2689145A1 Pressure-enhanced extraction and partitioning of molecules
12/10/2008EP2000535A1 Circovirus sequences associated with porcine wasting disease (PWD)
12/10/2008EP1606411B1 Mutant vesicular stomatitis viruses and use thereof
12/10/2008EP1017791B1 Recombinant respiratory syncytial virus expression systems and vaccines
12/10/2008CN101321865A High production system for infectious hepatitis C virus particle
12/10/2008CN101321455A Engrafted plants resistant to viral diseases and methods of producing same
12/10/2008CN101319202A HCMV-Towne-GFP recombined cytomegalovirus, preparation method and application thereof
12/10/2008CN101318016A Multivalent human-bovine rotavirus vaccine
12/09/2008US7462479 Immunizing an avian with nonpathogenic immunogenically strain of Georgia 98 (GA-98) virus in attenuated or inactivated form; poultry vaccines
12/09/2008US7462462 Peptide capable of binding to nanographite structures
12/09/2008US7462356 Chimeric papillomavirus-like particles
12/09/2008CA2202652C Production of peptides in plants as viral coat protein fusions
12/09/2008CA2183151C Host-vector system for use in gene therapy
12/04/2008WO2008147735A1 Identification of adaptive mutations that increase infectivity of hepatitis c virus jfh1 strain in cell culture
12/04/2008WO2008147496A2 Neuraminidase-deficient live influenza vaccines
12/04/2008WO2008145606A1 New mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance
12/04/2008WO2008145021A1 A truncated l1 protein of human papillomavirus 6
12/04/2008WO2008145020A1 A truncated l1 protein of human papillomavirus 11
12/04/2008WO2008103380A3 Hepatitis b virus compositions and methods of use
12/04/2008US20080299642 Vectors with modified protease-dependent tropism
12/04/2008US20080299641 Used to control the growth of E. coli O157:H7; extracellular matrix (ECMl); to control or prevent the infection or colonization of processed and unprocessed food products
12/04/2008US20080299131 Anti-Viral Compositions
12/04/2008US20080299083 Adenoviral vectors having a protein IX deletion
12/04/2008US20080299082 Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof
12/04/2008CA2688278A1 New mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance
12/03/2008EP1997900A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
12/03/2008EP1997891A1 Generation and selection of recombinant varied binding proteins
12/03/2008EP1294858B1 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
12/03/2008CN101316617A Countermeasure against infection with floating virus
12/03/2008CN100439516C Pig breeding and respiration syndrome virus ultrastrong variation strain RT-PCR reagent case
12/03/2008CN100439494C Swine reproduction and respiration syndrome vaccine and its prepn process and application
12/02/2008US7459272 In order to produce lytic infections in pathogenic bacteria to prevent infection, especially post-surgery
12/02/2008US7459270 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
12/02/2008US7459163 Infectious DNA as a vaccine against west nile and other flaviviruses
12/02/2008US7459162 Avian pandemic; immunogens; antibodies; immunology
12/02/2008US7459160 Chimeric flaviviruses
11/2008
11/27/2008WO2008144700A2 Simian t-cell lymphotropic virus type 3 west african subtype d
11/27/2008WO2008141651A1 Efficient cell culture system for hepatitis c virus genotype 5a
11/27/2008WO2008141448A1 Mutant reoviruses and methods of making and using
11/27/2008WO2008141400A1 A novel aetiologic agent of acute gastroenteritis (age), diagnostic methods and therapeutic treatment thereof
11/27/2008WO2007134037A3 Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
11/27/2008WO2007126959A3 Methods and compositions for inducing an immune response to hiv and models for testing
11/27/2008WO2007121429A3 Methods and compositions for the synergistic activation of latent hiv
11/27/2008WO2007098326A3 Method for screening hiv drug sensitivity
11/27/2008WO2007095055A3 Methods and compositions for detecting viral nucleic acid in a cell
11/27/2008US20080293123 Compositions comprising viruses and methods for concentrating virus preparations
11/27/2008US20080293040 Influenza b viruses with reduced sensitivity to neuraminidase inhibitors
11/27/2008US20080292658 Defective Influenza Virus Particles
11/27/2008US20080292657 Primate t-lymphotropic viruses
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292653 Live attenuated antigenically marked classical swine fever virus
11/27/2008US20080292652 Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide
11/27/2008US20080292594 reduced expression of a sigma3 polypeptide; used to generate and stably propagate infectious subviral particle (ISVP); proliferative disorder
11/27/2008US20080292592 treating, preventing cancer using compositions including replication competent adenovirus; death domains; rapid and efficient spread through the tumor
11/27/2008CA2688724A1 Novel simian t-cell lymphotropic virus
11/27/2008CA2680661A1 Mutant reoviruses and methods of making and using
11/26/2008EP1995310A1 Novel methods for rescue of RNA viruses
11/26/2008EP1994159A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans
11/26/2008EP1994156A1 Chimeric tymovirus-like particles
11/26/2008EP1993603A1 Hepatitis c virus non structural fusion protein
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008CN201154094Y Virus inactivating device for blood of extracorporeal circulation in vivo
11/26/2008CN100436478C Novel pesticidal toxins
11/25/2008US7456251 HIV fusion inhibitor peptides with improved biological properties
11/25/2008US7456018 Human hepatoma lines, methods for obtaining same and uses thereof
11/25/2008US7456009 Adenovirus formulations
11/25/2008US7456008 Modified virus comprising one or more non-native polypeptides
11/25/2008US7455994 Methods for producing Marburg virus proteins
11/25/2008US7455972 Determining presence, absence or quantity of murine Norovirus-1 (MNV-1) in a murine tissue, organ or feces sample by synthesizing complementary DNA from the sample RNA and detecting MNV-1 cDNA if present by a Polymerase chain reaction if MNV-1
11/25/2008US7455969 Highly permissive cell lines for hepatitis C virus RNA replication
11/25/2008US7455842 Chimeric West Nile viruses and uses thereof
11/20/2008WO2008141151A2 Synthetic herpes simplex viruses type-1 for treatment of cancers
11/20/2008WO2008140622A2 Modified polymerases and attenuated viruses and methods of use thereof
11/20/2008WO2008140621A2 Transgenic oncolytic viruses and uses thereof
11/20/2008WO2008140610A2 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
11/20/2008WO2008140414A1 Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
11/20/2008WO2008138533A1 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
11/20/2008WO2008118662A3 Imprinted polymeric materials for binding various targets such as viruses
11/20/2008WO2008089094A3 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus
11/20/2008WO2008048976A3 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors
11/20/2008WO2008043033A3 Fibrillation-resistant insulin and insulin analogues
11/20/2008WO2007098267A3 Pseudoinfectious flavivirus and uses thereof
11/20/2008US20080287654 Peptide mediated synthesis of metallic and magnetic materials
11/20/2008US20080286850 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
11/20/2008US20080286849 Herbal extract having anti-virus activity and preparation of same
11/20/2008US20080286848 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
11/20/2008US20080286836 Retroviral gene transfer element for enhancement of heterologous gene sequences in cells
11/20/2008US20080286779 Host Cells Containing Multiple Integrating Vectors
11/20/2008US20080286308 Respiratory disease in cattle; immunostimulants; bioassay
11/20/2008US20080286307 Two-Step Temperature Profile for the Propagation of Viruses
11/20/2008US20080286294 Nodavirus-Vlp Immunization Composition
11/20/2008US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
11/20/2008US20080286238 Recombinant Adenovirus Expressing A Gene Encoding Streptolysin O Proetin and Anti-Cancer Composition Comprising Same
11/20/2008US20080283775 Methods and Devices for Rapidly Forming Vitreous Ice-Jacketed Particle Droplets
11/20/2008CA2687301A1 Synthetic herpes simplex viruses type-1 for treatment of cancers
11/20/2008CA2687146A1 Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
11/20/2008CA2676149A1 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
11/20/2008CA2673535A1 Modified polymerases and attenuated viruses and methods of use thereof
11/20/2008CA2673355A1 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
11/19/2008EP1992696A1 Circovirus sequences associated with porcine wasting disease (PWD)
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 267